Answer:
quicker recovery period for limitless injuries and surgeries
Explanation:
its correct
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Answer:
The answer is "Option C and Option D"
Explanation:
FRAP is used only for protein motion management. It travels throughout two dimensions in the plasma membrane. It includes many available-moving or immobile proteins. This technology uses globally marked fluorescent bleaching products, and also includes the fluorescent proteins, but one particular area is washed.
Its protein arc changes are detected by fluorescence reappearance. The fluorescence reappears at a certain stage if the protein can move freely.
When the proteins aren't able to move quickly, fluorescent dyes are recovered after a little period, and fluorescence would not resurface during that point if the enzyme is immobile.
Human beings contribute to the phosphorus and sulfur cycles by using chemical fertilizers for the soil. This includes mostly synthetic fertilizers that can often be full of various molecules that include phosphorus and sulfur in them.
